Interim results of a joint feasibility study conducted by TTI and the Wilmot Cancer Institute, involving the use of Wave Health, were selected for oral abstract presentation at the 2024 Oncology Nursing Society (ONS) Congress in Washington, D.C.

Presented at the 2024 ASCO Genitourinary Cancers Symposium, PRO-WAVE1 Research Results Showcase Opportunity to Operationalize the Patient-Provider Connection to Better Manage Cancer Care

The Wave Health digital health platform, used to collect patient symptom and quality of life information in an innovative research study, comprises two abstracts accepted to the 2023 ASCO Annual Meeting.

An article recently published in ASCO reveals the significant impact of electronic patient-reported outcomes (ePROs) on providing patient-centered cancer care.

Inspire is the official publication of the NCODA Professional Student Organization. It engages young healthcare professionals with the latest news and insights in oncology pharmacy. Check out the latest issue of Inspire to read about how Wave Health is improving patient care!

This past week, CEO of TTI and creator of Wave Health, Matt Lashey, was featured on Entrepreneur Rx Podcast hosted by John Shufeldt, MD. Check out the interview here!

Recently, researchers at the University of Manchester and the Christie NHS Foundation Trust in the UK performed a systematic review of patient-facing cancer apps, in which Wave Health’s technology was validated as one of the leading ePRO platforms for oncology.

The story of Ric Grenell and his cancer battle, which led to the creation of Wave App, was Featured on Newsmax TV’s morning news show, Wake Up America.

A systemic review out of Cedars-Sinai Medical Center (CSMC) rated Wave as the #1 highest quality mHealth application to track patient-reported outcomes (PROs) for oncology patients.

Wave App is now available for FREE on all mobile iPhone and Android platforms, as well as some wearable devices and tablets, for people with chronic illness or conditions to take control of their health and manage daily treatment.